168 related articles for article (PubMed ID: 34969957)
1. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.
Puls F; Carter JM; Pillay N; McCulloch TA; Sumathi VP; Rissler P; Fagman H; Hansson M; Amary F; Tirabosco R; Magnusson L; Nilsson J; Flanagan AM; Folpe AL; Mertens F
Mod Pathol; 2022 Jun; 35(6):767-776. PubMed ID: 34969957
[TBL] [Abstract][Full Text] [Related]
2. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
[TBL] [Abstract][Full Text] [Related]
3. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases.
Anderson WJ; Mertens F; Mariño-Enríquez A; Hornick JL; Fletcher CDM
Am J Surg Pathol; 2022 Oct; 46(10):1329-1339. PubMed ID: 35713642
[TBL] [Abstract][Full Text] [Related]
4. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity.
Zhao M; Yin X; He H; Fan Y; Ru G; Meng X
Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381
[TBL] [Abstract][Full Text] [Related]
5. Superficial CD34 fibroblastic tumors and PRDM10-rearranged soft tissue neoplasm: An evolving diagnosis.
Johnson C; Parsa L; Gibbs J; Sligh J
J Cutan Pathol; 2024 Jan; 51(1):11-14. PubMed ID: 37150806
[TBL] [Abstract][Full Text] [Related]
6. PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 Cases.
Puls F; Pillay N; Fagman H; Palin-Masreliez A; Amary F; Hansson M; Kindblom LG; McCulloch TA; Meligonis G; Muc R; Rissler P; Sumathi VP; Tirabosco R; Hofvander J; Magnusson L; Nilsson J; Flanagan AM; Mertens F
Am J Surg Pathol; 2019 Apr; 43(4):504-513. PubMed ID: 30570551
[TBL] [Abstract][Full Text] [Related]
7. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
Hofvander J; Puls F; Pillay N; Steele CD; Flanagan AM; Magnusson L; Nilsson J; Mertens F
J Pathol; 2019 Dec; 249(4):425-434. PubMed ID: 31313299
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics.
Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T
Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703
[TBL] [Abstract][Full Text] [Related]
9. Superficial CD34 Positive Fibroblastic Tumour with Myxoid Stroma.
Bruce-Brand C; Conradie W; Schneider JW
Int J Surg Pathol; 2023 Aug; 31(5):751-754. PubMed ID: 36221951
[TBL] [Abstract][Full Text] [Related]
10. Superficial CD34-Positive Fibroblastic Tumor.
Perret R; Hostein I
Surg Pathol Clin; 2024 Mar; 17(1):1-12. PubMed ID: 38278599
[TBL] [Abstract][Full Text] [Related]
11. An update on selected cutaneous (myo) fibroblastic mesenchymal tumors.
Georgantzoglou N; Linos K
Semin Diagn Pathol; 2023 Jul; 40(4):295-305. PubMed ID: 37150655
[TBL] [Abstract][Full Text] [Related]
12. Superficial CD34-Positive Fibroblastic Tumor: A Newly Recognized Entity With Overlapping Features of PRDM10-Rearranged Soft Tissue Tumors.
Shaker N; Abu Shakra R; Sangueza OP
Cureus; 2023 Oct; 15(10):e47831. PubMed ID: 38021590
[TBL] [Abstract][Full Text] [Related]
13. Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma.
Hofvander J; Tayebwa J; Nilsson J; Magnusson L; Brosjö O; Larsson O; Vult von Steyern F; Mandahl N; Fletcher CD; Mertens F
Clin Cancer Res; 2015 Feb; 21(4):864-9. PubMed ID: 25516889
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical positive regulatory domain member 10 expression in soft tissue sarcomas.
Mistik O; Sayar H
Pol J Pathol; 2022; 73(3):223-232. PubMed ID: 36734437
[TBL] [Abstract][Full Text] [Related]
15. Superficial mesenchymal tumours expressing epithelial markers on immunohistochemistry: Diagnostic clues and pitfalls.
Andrei V; Haefliger S; Baumhoer D
Semin Diagn Pathol; 2023 Jul; 40(4):238-245. PubMed ID: 37147159
[TBL] [Abstract][Full Text] [Related]
16. Update on Cutaneous Soft Tissue Tumors.
Dermawan JK; Ko JS; Billings SD
Surg Pathol Clin; 2021 Jun; 14(2):195-207. PubMed ID: 34023100
[TBL] [Abstract][Full Text] [Related]
17. Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical features.
Salah HT; D'ardis JA; Baek D; Schwartz MR; Ayala AG; Ro JY
Ann Diagn Pathol; 2022 Jun; 58():151937. PubMed ID: 35344860
[TBL] [Abstract][Full Text] [Related]
18. Superficial CD34-Positive Fibroblastic Tumor.
Foot O; Hallin M; Bagué S; Jones RL; Thway K
Int J Surg Pathol; 2020 Dec; 28(8):879-881. PubMed ID: 32608310
[TBL] [Abstract][Full Text] [Related]
19. Fine needle aspiration cytology of a superficial CD34-positive fibroblastic tumour, including differential diagnoses and recent updates.
Rekhi B
Cytopathology; 2023 Jan; 34(1):66-71. PubMed ID: 36151940
[TBL] [Abstract][Full Text] [Related]
20. Superficial CD34-positive fibroblastic tumor: Cytologic features, tissue correlation, ancillary studies, and differential diagnosis of a recently described soft tissue neoplasm.
Li W; Molnar SL; Mott M; White E; De Las Casas LE
Diagn Cytopathol; 2016 Nov; 44(11):926-930. PubMed ID: 27432164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]